Articles

St. Jude Medical Optisure Defibrillation Lead

St. Jude Medical Inc. announced the global launch of the Optisure defibrillation lead.

Sorin Group has purchased Oscor Inc. lead business, including a lead manufacturing facility in the Dominican Republic for a value of approximately $20 million.

FDA Premarket Approval PMA Clinical Study EP Lab Cath Leads Implantable Devices

The U.S. Food and Drug Administration (FDA) has approved many cardiac implantable electronic device...

Boston scientific autogen x4 crt-d crt ICD heart failure cardiac

Boston Scientific Corp. has received CE mark approval of its X4 line of quadripolar ...

Medtronic Inc. announced U.S. Food and Drug Administration (FDA) approval of its Lead Integrity Alert (LIA) software for use with non-Medtronic ...

 Medtronic Inc. announced market release of the CardioGuide Implant System, a novel real-time navigation system for cardiac resynchronization therapy pacemakers and defibrillators (CRT-P and...

Cameron Health, Boston Scientific S-ICD subcutaneous implantable defibrillator

The U.S. Food and Drug Administration (FDA) has granted Boston Scientific Corp. regulatory approval for its S-ICD System, the world's first commercially available subcutaneous ...

The gloves are off and the fight has begun between St. Jude Medical and Medtronic over clinical data regarding their ...

April 6, 2012 — St. Jude Medical announced it is proactively informing physicians about visual observations of externalized conductors on the silicone end of QuickSite and QuickFlex left...

Cardiac rhythm device reliability and the approach to managing complications associated with these devices have recently been the topic of numerous medical and nonmedical publications.